Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Aprepitant and Palonosetron for CINV in HSCT
NCT00415103Phase 4Completed
- Sponsor
- Fundación PETHEMA
- Start
- Nov 2006
- Primary completion
- Sep 2009
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 4 trial of aprepitant, palonosetron in chemotherapy-induced nausea and vomiting (CINV), sponsored by Fundación PETHEMA. Started Nov 2006; status: completed.
02
Drugs
aprepitantpalonosetron
03
Conditions
chemotherapy-induced nausea and vomiting (CINV)
Beyond the preview
Go deeper on NCT00415103.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00415103.